Metraipolis › archive › dc_eab9c8a84353

Single-dose pharmacokinetics, tolerability, and physiologically based pharmacokinetic modeling of Fazamorexant in Chinese patients with hepatic impairment and… — Europe PMC PMID:42110531

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42110531
DOI
10.3389/fphar.2026.1814155
License (as archived)
solo-consultazione
Archived
2026-10-08T06:16:27.483Z
SHA-256 of the archived text
062e81a6b69ecd84c4bec0bf32e3ebfdd9f70e7174325e4f6b1b23bcffe3b960
Stable URL of this page
https://metraipolis.com/documento/dc_eab9c8a84353

How to cite

Single-dose pharmacokinetics, tolerability, and physiologically based pharmacokinetic modeling of Fazamorexant in Chinese patients with hepatic impairment and… — Europe PMC PMID:42110531 — Europe PMC (en), https://europepmc.org/article/MED/42110531 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_eab9c8a84353 (Metraipolis archive dc_eab9c8a84353, sha256 062e81a6b69ecd84c4bec0bf32e3ebfdd9f70e7174325e4f6b1b23bcffe3b960)
BibTeX
@misc{dceab9c8a84353,
  title = {Single-dose pharmacokinetics, tolerability, and physiologically based pharmacokinetic modeling of Fazamorexant in Chinese patients with hepatic impairment and… — Europe PMC PMID:42110531},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42110531},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_eab9c8a84353; sha256 062e81a6b69ecd84c4bec0bf32e3ebfdd9f70e7174325e4f6b1b23bcffe3b960},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42110531. Agents can read the archived copy with the MCP tool read_document.